CliffBio
small molecule

HYDROCORTISONE VALERATE

HYDROCORTISONE VALERATE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameHYDROCORTISONE VALERATE
Active ingredientHYDROCORTISONE VALERATE
Strength0.2%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalAugust 2019
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.